MACK

Merrimack Pharmaceuticals, Inc.
MACK

Overview Fund Activity
Delisted

MACK was delisted on the 17th of May, 2024.

Back to rankings

128 hedge funds and large institutions have $574M invested in Merrimack Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 32 reducing their positions, and 27 closing their positions.

Holders
128
Holders Change
-12
Holders Change %
-8.57%
% of All Funds
3.42%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
47
Reduced
32
Closed
27
Calls
$1.52M
Puts
$2.16M
Net Calls
-$631K
Net Calls Change
-$104K

Top Buyers

1
CCM
1
Consonance Capital Management
New York
$37.8M
2
GPP
2
Great Point Partners
Connecticut
$15.5M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$6.19M
4
State Street
4
State Street
Massachusetts
$29.2M
5
BFA
5
BlackRock Fund Advisors
California
$39.5M

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$57.2M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$0
3
LIM
3
Lagoda Investment Management
New York
$11.9M
4
GC
4
Guggenheim Capital
Illinois
$0
5
UBS AM
5
UBS AM
Illinois
$477K
Name Market Value Shares Shares
Change 		Shares
Change %
JFA
151
JNBA Financial Advisors
Minnesota
– – -1,250 Closed
Lazard Asset Management
152
Lazard Asset Management
New York
– – -930 Closed
QCG
153
Quadrant Capital Group
Ohio
– – -841 Closed
AOWM
154
Alpha Omega Wealth Management
Virginia
– – -200 Closed
WAM
155
Wolverine Asset Management
Illinois
– – – –
Wolverine Trading
156
Wolverine Trading
Illinois
– – – –
NFG
157
Next Financial Group
Texas
$0 23 +23 New
3 4 5 6
7